1. Home
  2. CAPL vs ALVO Comparison

CAPL vs ALVO Comparison

Compare CAPL & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CrossAmerica Partners

CAPL

CrossAmerica Partners

HOLD

Current Price

$22.76

Market Cap

889.1M

Sector

Energy

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$5.30

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAPL
ALVO
Founded
1992
2013
Country
United States
Luxembourg
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
889.1M
1.0B
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
CAPL
ALVO
Price
$22.76
$5.30
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$8.00
AVG Volume (30 Days)
41.9K
973.6K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
9.96%
N/A
EPS Growth
96.15
N/A
EPS
0.78
N/A
Revenue
$1,869,806,000.00
N/A
Revenue This Year
N/A
$13.28
Revenue Next Year
$2.80
$18.63
P/E Ratio
$29.74
$18.20
Revenue Growth
N/A
N/A
52 Week Low
$19.67
$2.94
52 Week High
$24.63
$9.25

Technical Indicators

Market Signals
Indicator
CAPL
ALVO
Relative Strength Index (RSI) 49.16 70.45
Support Level $22.37 $3.10
Resistance Level $24.63 $5.44
Average True Range (ATR) 0.49 0.26
MACD -0.09 0.00
Stochastic Oscillator 24.70 78.70

Price Performance

Historical Comparison
CAPL
ALVO

About CAPL CrossAmerica Partners

CrossAmerica Partners LP is engaged in the wholesale distribution of motor fuel and the ownership and leasing of real estate used in the retail distribution of motor fuel. The company operates through two business segments, namely Wholesale and Retail. The Wholesale segment is a key revenue driver and includes the wholesale distribution of motor fuel to lessee dealers, independent dealers, commission agents, DMS, Circle K, and through company-operated retail sites. The Retail segment includes the sale of convenience merchandise items, the retail sale of motor fuel at company-operated retail sites, and the retail sale of motor fuel at retail sites operated by commission agents.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: